Heterocycles as protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/4192 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2724715

Selected fused imidazole or triazole derivatives are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions in-volving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermedi-ates useful in such processes.

L'invention concerne des dérivés d'imidazole ou de triazole fusionnés sélectionnés qui sont efficaces pour la prophylaxie et le traitement de maladies, telles que des maladies à médiation par HGF. L'invention englobe de nouveaux composés, analogues, promédicaments et leurs sels de qualité pharmaceutique, des compositions pharmaceutiques et des procédés pour la prophylaxie et le traitement de maladies et d'autres affections ou troubles impliquant le cancer et autres. L'invention concerne également des procédés de préparation de tels composés ainsi que des intermédiaires utiles dans de tels procédés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocycles as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocycles as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycles as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1915586

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.